Abiopharma

🔍 Creal Thomas K IV (Executive)

Company: Northwest Bancshares, Inc. (NWBI)

Report Date: 2026-05-06

Detailed Transactions and Holdings:

• Acquired 10,733 shares of Northwest Bancshares, Inc. Common Stock at $9.71 per share (Direct)
  Date: 2026-05-06 | Code: M | equity_swap_involved: 0 | shares_owned_after: 60,783.26 | transaction_form_type: 4
• Sold 7,397 shares of Northwest Bancshares, Inc. Common Stock at $14.09 per share (Direct)
  Date: 2026-05-06 | Code: F | equity_swap_involved: 0 | shares_owned_after: 53,386.26 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Northwest Bancshares, Inc. Common Stock (Direct)
  Date: 2026-05-06 | Code: H | nature_of_ownership: 401-K | shares_owned_after: 5,165.31
• Sold 10,733 shares of Stock Options (Right to Buy) at $9.71 per share (Derivative)
  Date: 2026-05-06 | Code: M | Expires: 2030-05-20 | Exercise: 2020-05-20 | equity_swap_involved: 0 | shares_owned_after: 1,747.00 | transaction_form_type: 4

Footnotes:

• F1: Sale of shares to cover the exercise price, withholding tax obligations and broker fees and commissions, pursuant to a broker assisted cashless exercise of fully vested stock options.